You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • TP011/#1536  A double-blind placebo-controlled phase III chemo-immunotherapy (Paclitaxel-carboplatin-oregovomab [PCO]) vs chemotherapy (Paclitaxel-carboplatin-placebo [PCP]) in patients with newly diagnosed, advanced epithelial ovarian cancer (EOC): FLOR…

Article metrics

Article menu

Download PDFPDF

ePoster Viewing: Trials-in-Progress
AS11. Ovarian cancer
TP011/#1536  A double-blind placebo-controlled phase III chemo-immunotherapy (Paclitaxel-carboplatin-oregovomab [PCO]) vs chemotherapy (Paclitaxel-carboplatin-placebo [PCP]) in patients with newly diagnosed, advanced epithelial ovarian cancer (EOC): FLORA-5/GOG-3035 study
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to October 2024

AbstractFullPdf
Nov 2023320024
Dec 202390010
Jan 20242203
Feb 20244704
Mar 20244105
Apr 20242801
May 20242302
Jun 20241800
Jul 20241404
Aug 20241504
Sep 20243002
Oct 2024602
Total654061